EP3475303
And-CD19 mótefnissamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.6.2017EP published:
14.4.2021EP application number:
17735440.4
EP translation filed:
20.5.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
26.6.2037Expiry date:
26.6.2026Next due date:
30.6.2026
Title:
ANTI-CD19 ANTIBODY FORMULATIONS
Timeline
Today
27.6.2017EP application
14.4.2021EP Publication
20.5.2021Translation submitted
15.6.2021Registration published
26.6.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
GARIDEL, PatrickAddress:
55216 Ingelheim am Rhein, DE
Name:
LANGER, AndreasAddress:
55216 Ingelheim am Rhein, DE
Name:
HESSLING, MartinAddress:
88400 Biberach, DE
Name:
WEINFURTNER, DanielAddress:
82152 Planegg, DE
Name:
BROCKS, BodoAddress:
82152 Planegg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16176322Date:
27.6.2016Country:
EP
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.6.2021
Expires: 26.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 1.6.2022
Expires: 26.6.2023
Payer: Patice ehf.
Number: 7
Paid: 11.6.2023
Expires: 26.6.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.6.2024
Expires: 26.6.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 26.6.2025
Expires: 26.6.2026
Payer: Árnason Faktor ehf.